B-cell reconstitution and BAFF after alemtuzumab (Campath-1H) treatment of multiple sclerosis. [electronic resource]
Producer: 20100614Description: 99-105 p. digitalISSN:- 1573-2592
- Adolescent
- Adult
- Alemtuzumab
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antibodies, Neoplasm -- administration & dosage
- B-Cell Activating Factor -- biosynthesis
- B-Lymphocytes -- drug effects
- Cell Differentiation -- drug effects
- Cell Survival -- drug effects
- Cells, Cultured
- Female
- Follow-Up Studies
- Humans
- Immunologic Memory -- drug effects
- Immunophenotyping
- Male
- Middle Aged
- Multiple Sclerosis, Relapsing-Remitting -- blood
- T-Lymphocytes -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.